This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Astrazeneca Ab, Mitsubishi Tanabe Pharma Corporation. Active years: 2008-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Mölndal, SE (2008)
- Göthenburg, SE (2023)
Company Filing History:
2 out of 1,534 
1 out of 263 
Years Active: 2008-2023
Title: Stig Jonas Boström: Innovator in Pharmaceutical Compounds
Introduction
Stig Jonas Boström is a notable inventor based in Gothenburg, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have therapeutic applications.
Latest Patents
Boström holds 2 patents that focus on innovative compounds and their uses. His latest patents include compounds of Formula (I) that are modulators of RXFP1, which may be useful as therapeutic agents for treating various diseases and conditions such as heart failure and chronic kidney disease. Additionally, he has developed compounds that address obesity, psychiatric, and neurological disorders, showcasing his versatility in pharmaceutical research.
Career Highlights
Throughout his career, Boström has worked with prominent companies in the pharmaceutical industry, including AstraZeneca and Mitsubishi Tanabe Pharma Corporation. His work has contributed to advancements in drug development and therapeutic solutions.
Collaborations
Boström has collaborated with notable professionals in the field, including Kenneth Lars Granberg and Shigeki Sakamaki. These collaborations have further enhanced his research and development efforts.
Conclusion
Stig Jonas Boström's innovative work in pharmaceutical compounds has made a significant impact on the industry. His contributions continue to pave the way for new therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile